IDEAYA BIOSCIENCES INC (IDYA)
NASDAQ • Healthcare
$37.93
+$1.39 (+3.8%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About IDEAYA BIOSCIENCES INC
Name
IDEAYA BIOSCIENCES INC
CEO
Yujiro S. Hata
Website
Industry
Healthcare
Year Founded
2015
Employees
145
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is a biotechnology company focused on precision oncology, developing targeted cancer medicines for molecularly defined patient groups. In FY2025, it generated $218.7 million in revenue. The company centers its approach on synthetic lethality, using genetic and molecular diagnostic selection to match therapies to specific tumor vulnerabilities.
Fundamentals & Financials
Revenue (TTM)
$234.1M
Net Income (TTM)
-$175M
EPS (TTM)
-$1.92
ROA (TTM)
-13.36%
Current Ratio
10.45
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$37.93$36.39 - $37.98
52 Week RangeAvg. Volume$23.23 - $40.58685.7K
Market Cap$3.6B
Peers & Related Assets
SRRKSCHOLAR ROCK HOLDING CORP
$54.72+5.1%
COGTCOGENT BIOSCIENCES INC
$37.4-1.2%
ADPTADAPTIVE BIOTECHNOLOGIES CORP
$24.56-0.8%
BEAMBEAM THERAPEUTICS INC
$26.57-2.0%
MLYSMINERALYS THERAPEUTICS INC
$26.61+2.1%
KNSAKiniksa Pharmaceuticals International, plc
CDTXCidara Therapeutics, Inc.
FOLDAmicus Therapeutics, Inc.
LEGNLegend Biotech Corporation
ZLABZai Lab Limited